We found that IgM− gut bacteria (including IgA+, IgG+ and non-Ig-bound bacteria) from participants with NGT had higher α diversity, compared with participants with either IGT or type 2 diabetes (Fig. 6b). The gene discussed is CD79A; the disease is type 2 diabetes mellitus.